-
Something wrong with this record ?
Transactivation and reactivation capabilities of temperature-dependent p53 mutants in yeast and human cells
J. Jagosova, L. Pitrova, J. Slovackova, B. Ravcukova, J. Smarda, J. Smardova,
Language English Country Greece
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 2006 to 1 year ago
ProQuest Central
from 2012-01-01
Nursing & Allied Health Database (ProQuest)
from 2012-01-01
Health & Medicine (ProQuest)
from 2012-01-01
PubMed
22710932
DOI
10.3892/ijo.2012.1520
Knihovny.cz E-resources
- MeSH
- Transcriptional Activation * MeSH
- Amifostine pharmacology MeSH
- Genes, p53 * MeSH
- Yeasts genetics MeSH
- Humans MeSH
- Mutation MeSH
- Tumor Suppressor Protein p53 genetics metabolism MeSH
- Radiation-Protective Agents pharmacology MeSH
- Temperature MeSH
- Transformation, Genetic MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The p53 protein is a sequence-specific transcription factor controlling the expression of multiple genes and protecting cells from oncogenic transformation. In many tumors, the p53 protein is completely or partially inactivated by mutations in the p53 gene. We analyzed the transactivating activity of nine human temperature-dependent (td) p53 mutants in yeast cells. Mutations in seven of them were localized in the β-sandwich-coding region of the p53 gene, eight p53 mutants were temperature-sensitive and the R283C mutant was cold-sensitive. Patterns of their transactivation abilities towards three different responsive elements, the extent of their temperature dependency as well as discriminativity, were considerably variable. Similarly, their capacity to become reactivated by amifostine varied from complete resistance to high sensitivity. Transactivation abilities and temperature dependency of six p53 td mutants were determined in transiently-transfected H1299 human cells and revealed substantial concordance between the activity patterns of the p53 mutants in yeast and human cells. We concluded that the td p53 mutants do not comprise a uniform group, therefore, the behavior of each mutant has to be tested individually.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012640
- 003
- CZ-PrNML
- 005
- 20130411101212.0
- 007
- ta
- 008
- 130404s2012 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3892/ijo.2012.1520 $2 doi
- 035 __
- $a (PubMed)22710932
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Jagosova, Jana $u Department of Pathology, University Hospital Brno, 625 00 Brno, Czech Republic.
- 245 10
- $a Transactivation and reactivation capabilities of temperature-dependent p53 mutants in yeast and human cells / $c J. Jagosova, L. Pitrova, J. Slovackova, B. Ravcukova, J. Smarda, J. Smardova,
- 520 9_
- $a The p53 protein is a sequence-specific transcription factor controlling the expression of multiple genes and protecting cells from oncogenic transformation. In many tumors, the p53 protein is completely or partially inactivated by mutations in the p53 gene. We analyzed the transactivating activity of nine human temperature-dependent (td) p53 mutants in yeast cells. Mutations in seven of them were localized in the β-sandwich-coding region of the p53 gene, eight p53 mutants were temperature-sensitive and the R283C mutant was cold-sensitive. Patterns of their transactivation abilities towards three different responsive elements, the extent of their temperature dependency as well as discriminativity, were considerably variable. Similarly, their capacity to become reactivated by amifostine varied from complete resistance to high sensitivity. Transactivation abilities and temperature dependency of six p53 td mutants were determined in transiently-transfected H1299 human cells and revealed substantial concordance between the activity patterns of the p53 mutants in yeast and human cells. We concluded that the td p53 mutants do not comprise a uniform group, therefore, the behavior of each mutant has to be tested individually.
- 650 _2
- $a amifostin $x farmakologie $7 D004999
- 650 12
- $a geny p53 $7 D016158
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a radioprotektivní látky $x farmakologie $7 D011837
- 650 _2
- $a teplota $7 D013696
- 650 12
- $a aktivace transkripce $7 D015533
- 650 _2
- $a transformace genetická $7 D014170
- 650 _2
- $a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
- 650 _2
- $a kvasinky $x genetika $7 D015003
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pitrova, Lenka $u -
- 700 1_
- $a Slovackova, Jana $u -
- 700 1_
- $a Ravcukova, Barbora $u -
- 700 1_
- $a Smarda, Jan $u -
- 700 1_
- $a Smardova, Jana $u -
- 773 0_
- $w MED00002350 $t International journal of oncology $x 1791-2423 $g Roč. 41, č. 3 (2012), s. 1157-63
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22710932 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20130411101442 $b ABA008
- 999 __
- $a ok $b bmc $g 975838 $s 810921
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 41 $c 3 $d 1157-63 $i 1791-2423 $m International journal of oncology $n Int J Oncol $x MED00002350
- LZP __
- $a Pubmed-20130404